Stock Analysis

These 4 Measures Indicate That Alkyl Amines Chemicals (NSE:ALKYLAMINE) Is Using Debt Extensively

NSEI:ALKYLAMINE
Source: Shutterstock

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We note that Alkyl Amines Chemicals Limited (NSE:ALKYLAMINE) does have debt on its balance sheet. But should shareholders be worried about its use of debt?

Why Does Debt Bring Risk?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

View our latest analysis for Alkyl Amines Chemicals

What Is Alkyl Amines Chemicals's Debt?

The image below, which you can click on for greater detail, shows that at September 2023 Alkyl Amines Chemicals had debt of ₹907.2m, up from ₹637.0m in one year. However, because it has a cash reserve of ₹154.5m, its net debt is less, at about ₹752.7m.

debt-equity-history-analysis
NSEI:ALKYLAMINE Debt to Equity History December 27th 2023

How Healthy Is Alkyl Amines Chemicals' Balance Sheet?

The latest balance sheet data shows that Alkyl Amines Chemicals had liabilities of ₹2.94b due within a year, and liabilities of ₹798.6m falling due after that. On the other hand, it had cash of ₹154.5m and ₹2.20b worth of receivables due within a year. So its liabilities total ₹1.38b more than the combination of its cash and short-term receivables.

This state of affairs indicates that Alkyl Amines Chemicals' balance sheet looks quite solid, as its total liabilities are just about equal to its liquid assets. So it's very unlikely that the ₹131.3b company is short on cash, but still worth keeping an eye on the balance sheet. But either way, Alkyl Amines Chemicals has virtually no net debt, so it's fair to say it does not have a heavy debt load!

We use two main ratios to inform us about debt levels relative to earnings. The first is net debt divided by earnings before interest, tax, depreciation, and amortization (EBITDA), while the second is how many times its earnings before interest and tax (EBIT) covers its interest expense (or its interest cover, for short). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

Alkyl Amines Chemicals's net debt is only 0.28 times its EBITDA. And its EBIT easily covers its interest expense, being 82.5 times the size. So we're pretty relaxed about its super-conservative use of debt. It is just as well that Alkyl Amines Chemicals's load is not too heavy, because its EBIT was down 23% over the last year. Falling earnings (if the trend continues) could eventually make even modest debt quite risky. The balance sheet is clearly the area to focus on when you are analysing debt. But it is future earnings, more than anything, that will determine Alkyl Amines Chemicals's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

Finally, a company can only pay off debt with cold hard cash, not accounting profits. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. In the last three years, Alkyl Amines Chemicals created free cash flow amounting to 6.1% of its EBIT, an uninspiring performance. For us, cash conversion that low sparks a little paranoia about is ability to extinguish debt.

Our View

We feel some trepidation about Alkyl Amines Chemicals's difficulty EBIT growth rate, but we've got positives to focus on, too. For example, its interest cover and net debt to EBITDA give us some confidence in its ability to manage its debt. Looking at all the angles mentioned above, it does seem to us that Alkyl Amines Chemicals is a somewhat risky investment as a result of its debt. That's not necessarily a bad thing, since leverage can boost returns on equity, but it is something to be aware of. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. For example - Alkyl Amines Chemicals has 1 warning sign we think you should be aware of.

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

Valuation is complex, but we're helping make it simple.

Find out whether Alkyl Amines Chemicals is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.